Results

Total Results: 434 records

Showing results for "last months".

321. Archived: Evidence Summary: Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis-june-2019
     June 11, 2019 - PrEP was associated with decreased risk of HIV infection vs placebo or no PrEP after 4 months to 4 years … The last surveillance was conducted on January 25, 2019, and identified no eligible randomized trials … Duration of follow-up ranged from 4 months to 4 years. … enrolled between 20 and 1086 study participants (total n = 3177), and duration of PrEP use ranged from 6 months

322. Anxiety Screening: Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/CXDusYW7s2xdypXMpnW9sw
     June 20, 2023 - The last surveillance was conducted on November 25, 2022, and identified no studies affecting review … in improve- ment of only 0.83 (standard error not reported) points on a 16- point anxiety scale at 3 months … follow-up in anxiety symptom levels or in any of the 36-Item Short Form Health Survey subscale scores at 5 months … for a general adult population or older adults taking antide- pressants or benzodiazepines for 1 to 3 months

323. Recommendation: Impaired Visual Acuity in Older Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/impaired-visual-acuity-screening-older-adults
     May 24, 2022 - Practice About half of US adults older than 65 years reported having an eye examination within the last … 12 months in a 2007 study. 30 The Snellen eye chart or the Early Treatment Diabetic Retinopathy Study

324. JAMA (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/DQgVKNYn6gFtXLfwthuRBU
     June 12, 2020 - Practice About half of US adults older than 65 years reported having an eye examination within the last … 12 months in a 2007 study.30 The Snellen eye chart or the Early Treatment Diabetic Retinopathy Study

325. Archived: Evidence Summary: Collaborative Modeling of U.S. Breast Cancer Screening Strategies: Breast Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-collaborative-modeling-of-us-breast-cancer-/breast-cancer-screening-january-2016
     January 11, 2016 - Performance characteristics of digital mammography depend on age, first versus subsequent screen, time since last … interval, using standard BCSC definitions: "Annual" includes data from screens occurring within 9 to 18 months … of the prior screen, and "biennial" includes data on screens within 19 to 30 months. 37 , 38 Model … initial treatment by stage (for the first 2 years after diagnosis), and having distant disease (for the last

326. Screening and Treatment for Hypercholesterolemia in Children and Adolescents: Systematic Evidence Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/CW23r2jqogvTG2_-kBjRxH
     January 01, 2007 - cholestyramine reported transient increases in LDH and abnormalities in AST that persisted for six months … (Apo)lipoprotein(a) concentrations at birth and in the first days and months of life--studies on the … Pharmacol. 2004;57(4):525-528. 206. de Jongh S, Kerckhoffs MC, Grootenhuis MA, Bakker HD, Heymans HS, Last … (Apo)lipoprotein(a) concentrations at birth and in the first days and months of life--studies on the … Pharmacol. 2004;57(4):525-528. 206. de Jongh S, Kerckhoffs MC, Grootenhuis MA, Bakker HD, Heymans HS, Last

327. Archived: Evidence Summary: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary27/breast-cancer-medications-for-risk-reduction-2013
     April 15, 2013 - Three months after viewing the decision aid, 1% of women had started taking tamoxifen, 6% had talked … mailed survey, 27% had prescribed tamoxifen for breast cancer risk reduction within the previous 12 months … 41% of participants took 100% of study medication and 79% took at least 76% of study medication at 36 months … Forgetting was the primary reason for nonadherence for 62% of women at 36 months. … SEER) DCIS or invasive breast cancer in women aged 35–84 y who had previous mammography within the last

328. Archived: Final Evidence Review: Ovarian Cancer: Screening, May 2004 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review79/ovarian-cancer-screening-2004
     May 15, 2004 - update will focus on studies of screening and performance of detection technologies available since the last

329. Archived: Evidence Summary: Chronic Obstructive Pulmonary Disease: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/chronic-obstructive-pulmonary-disease-screening-2016
     April 05, 2016 - and harms of treating screen-detected patients (generally those with mild to moderate COPD) since the last … The last surveillance was conducted on January 22, 2016, and identified no new studies. … biochemically validated abstinence in the intervention group compared with the control group rates after 12 months … e Parkes et al, 41 2008 561 Aged ≥35 y; patient record indicates was a smoker within the last

330. Use of Medications to Reduce Risk for Primary Breast Cancer: A Systematic Review of the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/7ZSKduUYHWKe7q_tTY9xbF
     April 01, 2013 - Three months after viewing the decision aid, 1% of ReviewUse of Medications to Reduce Risk for Primary … mailed survey, 27% had prescribed tamoxifen for breast cancer risk reduction within the previous 12 months … of participants took 100% of study medication and 79% took at least 76% of study medica- tion at 36 months … Forgetting was the primary reason for nonadherence for 62% of women at 36 months. … SEER) DCIS or invasive breast cancer in women aged 35–84 y who had previous mammography within the last

331. Evidence Summary: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/aspirin-to-prevent-cardiovascular-disease-preventive-medication
     April 26, 2022 - patient data meta-analyses and if they examined regular oral aspirin use (≥75 mg every other day for 12 months

332. 12th Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/2022-annual-report-to-congress.pdf
     January 01, 2022 - expectancy and a reduced risk of developing a chronic disease.1 Chronic diseases are conditions that last … posted 12 final evidence reports • For a listing of all final USPSTF recommendations released since the last … THE USPSTF IN 2023 In the coming 12 months, it is expected that the USPSTF will continue to: Develop … recommends that primary care clinicians prescribe oral fluoride supplementation starting at age 6 months

333. Secyfgzqgdoqdd8J4Ccvuy (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/SEcYfGZqGdoqdd8j4CCVuy
     May 01, 2008 - At 3 months’ postpartum, 3 SF-36 components (physical functioning, general health, and overall physical … Fasting or two-hour postprandial plasma glucose levels in early months of pregnancy as screening tools … for gestational diabetes mellitus developing in later months of pregnancy. … Height, weight, and motor-social development during the first 18 months of life in 126 infants born to … Impact of time since last meal on the gestational glucose challenge test.

334. Archived: Final Evidence Summary: Gestational Diabetes: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary26/gestational-diabetes-screening-2008
     May 15, 2008 - At 3 months' postpartum, 3 SF-36 components (physical functioning, general health, and overall physical … Fasting or two-hour postprandial plasma glucose levels in early months of pregnancy as screening tools … for gestational diabetes mellitus developing in later months of pregnancy. … Height, weight, and motor-social development during the first 18 months of life in 126 infants born to … Impact of time since last meal on the gestational glucose challenge test.

335. Pdf (pdf file)
     www.uspreventiveservicestaskforce.org/Home/GetFile/1/588/gdart/pdf
     May 01, 2008 - At 3 months’ postpartum, 3 SF-36 components (physical functioning, general health, and overall physical … Fasting or two-hour postprandial plasma glucose levels in early months of pregnancy as screening tools … for gestational diabetes mellitus developing in later months of pregnancy. … Height, weight, and motor-social development during the first 18 months of life in 126 infants born to … Impact of time since last meal on the gestational glucose challenge test.

336. Screening for Intimate Partner Violence and Abuse of Elderly and Vulnerable Adults: USPSTF Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/aSTzfuKHZtT8_PjfJjuck5
     March 01, 2013 - Primary outcomes were exposure to abuse and quality of life in the 18 months after screening.

337. Archived: Final Evidence Summary: Low-Dose Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary51/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication-september-2014
     April 08, 2014 - Between the last search date and this publication, we actively monitored published literature for potentially … Study in Pregnancy) trial reported no differences in developmental outcomes of the infants up to age 18 months … from one large RCT were reassuring 62 , with no differences in physical or mental development at 18 months

338. Final Evidence Summary: Depression and Suicide Risk in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary27/screening-depression-suicide-risk-children-adolescents
     October 11, 2022 - The last surveillance was conducted on June 1, 2022. … attention control. 60 Duration of treatment ranged between 1 single session to weekly sessions over 12 months … no statistically significant differences in suicide deaths at the end of treatment (19 weeks to 12 months

339. Screening for Ovarian Cancer: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/cHbBWNok76hRWKDXXm3R2_
     February 13, 2018 - The last surveillance, conducted on November 22, 2017, identified an additional publication reporting … intervention and control groups was ob- served when computed from the date of randomization (median, 72.9 months … for intervention group vs 41.8 months for control group; P = .01). … protocol-defined follow-up.34 This protocol-defined follow-up in- cluded retesting with CA-125 in 6 months

340. Preexposure Prophylaxis for the Prevention of HIV Infection: Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/bQNXFv9Q5uaAQvWH6B7VWV
     June 11, 2019 - PrEP was associated with decreased risk of HIV infection vs placebo or no PrEP after 4 months to 4 years … The last sur- veillance was conducted on January 25, 2019, and identified no eli- gible randomized trials … Duration of follow-up ranged from 4 months to 4 years. … enrolled between 20 and 1086 study participants (total n = 3177), and duration of PrEP use ranged from 6 months